AIP
STRO icon

Ameritas Investment Partners’s Sutro Biopharma STRO Stock Holding History

Ameritas Investment Partners’s Portfolio STRO Stock Details STRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$48.1K Buy
+1,448
New +$45.1K ﹤0.01% 2279
2025
Q2 		– Sell
-662
Closed -$4.31K – 3338
2025
Q1 		$4.31K Hold
662
– – ﹤0.01% 3000
2024
Q4 		$12.2K Hold
662
– – ﹤0.01% 2852
2024
Q3 		$22.9K Buy
662
+165
+33% +$6.47K ﹤0.01% 2579
2024
Q2 		$14.6K Hold
497
– – ﹤0.01% 2761
2024
Q1 		$28.1K Hold
497
– – ﹤0.01% 2432
2023
Q4 		$21.3K Hold
497
– – ﹤0.01% 2560
2023
Q3 		$17.2K Hold
497
– – ﹤0.01% 2605
2023
Q2 		$23.1K Buy
497
+157
+46% +$7.82K ﹤0.01% 2492
2023
Q1 		$15.7K Hold
340
– – ﹤0.01% 2546
2022
Q4 		$25.6K Hold
340
– – ﹤0.01% 2452
2022
Q3 		$18K Hold
340
– – ﹤0.01% 2577
2022
Q2 		$17K Hold
340
– – ﹤0.01% 2637
2022
Q1 		$28K Hold
340
– – ﹤0.01% 2406
2021
Q4 		$51K Hold
340
– – ﹤0.01% 2119
2021
Q3 		$64K Hold
340
– – ﹤0.01% 1992
2021
Q2 		$63K Buy
340
+76
+29% +$14.9K ﹤0.01% 2034
2021
Q1 		$60K Buy
264
+42
+19% +$9.97K ﹤0.01% 1980
2020
Q4 		$48K Hold
222
– – ﹤0.01% 2017
2020
Q3 		$22K Buy
222
+74
+50% +$6.99K ﹤0.01% 2329
2020
Q2 		$12K Buy
148
+95
+179% +$9.12K ﹤0.01% 2638
2020
Q1 		$5K Hold
53
– – ﹤0.01% 2831
2019
Q4 		$6K Hold
53
– – ﹤0.01% 2883
2019
Q3 		$5K Hold
53
– – ﹤0.01% 2940
2019
Q2 		$6K Hold
53
– – ﹤0.01% 2930
2019
Q1 		$6K Hold
53
– – ﹤0.01% 2833
2018
Q4 		$5K Buy
+53
New +$6.4K ﹤0.01% 2863

Other funds holding STRO

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Ameritas Investment Partners's STRO Position: Q2 2026 in Review

Ameritas Investment Partners opened a new position in Sutro Biopharma (STRO) in Q2 2026: 1,448 shares worth $48.1K. The stake represents ﹤0.01% of the portfolio and ranks #2279 among its holdings. This is a return to the name: Ameritas Investment Partners previously reported a position in STRO as recently as Q1 2025.

Ameritas Investment Partners first reported a position in STRO in Q4 2018 and has held it in 27 quarters since. The position peaked at $64K in Q3 2021. 100 funds tracked by Wall St. Rank hold STRO as of Q2 2026.

  • Ameritas Investment Partners held 1,448 shares of Sutro Biopharma worth $48.1K as of Q2 2026.
  • Sutro Biopharma was a new Ameritas Investment Partners position in Q2 2026.
  • Sutro Biopharma made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q2 2026, its #2279 holding.
  • Ameritas Investment Partners first reported a position in Sutro Biopharma in Q4 2018 and has held it in 27 quarters since.
  • Ameritas Investment Partners's Sutro Biopharma position peaked at $64K in Q3 2021.
  • 100 funds tracked by Wall St. Rank held Sutro Biopharma as of Q2 2026.

Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.